# MBRX (Moleculin Biotech, Inc.) - SEC EDGAR Financial Statements

> Moleculin Biotech, Inc. reported $0 in revenue and a net loss of $11.42M for the trailing twelve months ended September 30, 2026.

- Canonical: https://convexityos.com/fundamentals/MBRX
- Markdown: https://convexityos.com/fundamentals/MBRX.md
- SEC CIK: 0001659617
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:07 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001659617&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Sep 30, 2026 |
| Operating Income | TTM | -$29.58M | Operating profit |
| Net Income | TTM | -$11.42M | GAAP bottom line |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -$22.73M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $7.29M | Total debt: $257K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $15.89M | $17.73M | $19.49M | $18.97M | $14.42M | $12.76M | $11.01M | $9.73M | $4.54M | $1.50M |
| Total Operating Expenses | $25.10M | $26.64M | $29.63M | $30.64M | $22.97M | $19.74M | $17.52M | $15.03M | $8.65M | $3.88M |
| **Operating Income** | -$25.10M | -$26.64M | -$29.63M | -$30.64M | -$22.97M | -$19.74M | -$17.52M | -$15.03M | -$8.65M | -$3.88M |
| **EBITDA** | -$25.01M | -$26.52M | -$29.50M | -$30.51M | -$22.80M | -$19.54M | -$17.32M | -$14.96M | -$8.63M | -$3.88M |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $43K |
| Income Before Tax | -$33.56M | -$26.05M | -- | -- | -- | -$17.36M | -$13.43M | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$229K | $0 | $0 | $0 |
| **Net Income** | -$33.56M | -$26.05M | -$29.77M | -$29.02M | -$15.89M | -$17.36M | -$13.21M | -$11.88M | -$9.80M | -$3.93M |
| Basic EPS | -$355,250.00 | -$2,364,250.00 | -$188,375.00 | -$190,250.00 | -$110,625.00 | -$330,000.00 | -$365,625.00 | -$86,250.00 | -$99,375.00 | -$75,000.00 |
| **Diluted EPS** | -- | -- | -- | -- | -$110,625.00 | -$330,000.00 | -$365,625.00 | -$86,250.00 | -$99,375.00 | -$75,000.00 |
| Basic Shares Outstanding | 95 | 11 | 158 | 153 | 143 | 53 | 36 | 138 | 99 | 52 |
| Diluted Shares Outstanding | -- | -- | -- | -- | 143 | 53 | 36 | 138 | 99 | 52 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $4.49M | $5.45M | $5.38M | $5.12M | $3.74M | $3.60M | $3.44M | $4.46M |
| Total Operating Expenses | $6.61M | $7.56M | $7.87M | $7.53M | $5.91M | $5.72M | $5.94M | $6.64M |
| **Operating Income** | -$6.61M | -$7.56M | -$7.87M | -$7.53M | -$5.91M | -$5.72M | -$5.94M | -$6.64M |
| **EBITDA** | -$6.60M | -$7.55M | -$7.87M | -$7.52M | -$5.88M | -$5.69M | -$5.91M | -$6.61M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$6.49M | -$7.63M | -$12.85M | $15.55M | -$25.40M | -$17.81M | -$5.90M | -$6.58M |
| Basic EPS | -$9.59 | -$700.00 | -$1,770.00 | -- | -$340.43 | -$14,340.00 | -$7,900.00 | -- |
| Basic Shares Outstanding | 757.9K | 11.4K | 8.2K | -- | 74.6K | 1.2K | 748 | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.88M | $4.28M | $23.55M | $43.15M | $70.90M | $15.17M | $10.73M | $7.13M | $7.71M | $5.01M |
| **Cash & Short-Term Investments** | $8.88M | $4.28M | $23.55M | $43.15M | $70.90M | $15.17M | $10.73M | $7.13M | $7.71M | $5.01M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $1.0K | $56K | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- | -- | $529K | -- | -- | -- |
| **Total Current Assets** | $9.69M | $5.19M | $26.27M | $45.60M | $72.50M | $17.20M | $13.48M | $7.97M | $8.30M | $5.22M |
| Property, Plant & Equipment, Net | $78K | $159K | $272K | $275K | $338K | $483K | $316K | $463K | $33K | $23K |
| Other Non-Current Assets | $900K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $12.44M | $11.73M | $11.94M | $11.83M | $11.59M | $11.83M | $11.75M | $11.61M | $11.18M | $11.17M |
| **Total Assets** | $22.13M | $16.93M | $38.22M | $57.42M | $84.09M | $29.03M | $25.23M | $19.59M | $19.48M | $16.39M |
| Accounts Payable | $3.51M | $2.03M | $2.50M | $2.10M | $1.36M | $1.13M | $2.15M | $1.25M | $810K | $399K |
| **Total Current Liabilities** | $6.85M | $5.36M | $6.82M | $4.82M | $3.62M | $2.92M | $3.57M | $3.88M | $2.21M | $1.34M |
| **Total Non-Current Liabilities** | $266K | $358K | $5.33M | $412K | $1.48M | $8.35M | $6.09M | $1.44M | $150K | $88K |
| **Total Liabilities** | $7.12M | $5.72M | $12.14M | $5.23M | $5.10M | $11.27M | $9.66M | $5.31M | $2.37M | $1.43M |
| **Total Debt (incl. Leases)** | $359K | $478K | $574K | $451K | $159K | $277K | $379K | -- | -- | -- |
| Common Stock | $0 | $0 | $33K | $29K | $29K | $69K | $46K | $29K | $21K | $12K |
| Retained Earnings | -$206.0M | -$172.4M | -$131.6M | -$101.8M | -$72.81M | -$56.92M | -$39.56M | -$26.36M | -$14.48M | -$4.67M |
| Accumulated Other Comp. Income | $10K | -$41K | -- | -- | -- | -- | -- | -- | $0 | -- |
| **Total Stockholders' Equity** | $15.01M | $11.21M | $30.93M | $52.19M | $78.99M | $17.76M | $15.57M | $14.27M | $17.12M | $14.96M |
| Total Equity | $15.01M | $11.21M | $30.93M | $52.19M | $78.99M | $17.76M | $15.57M | $14.27M | $17.12M | $14.96M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $7.29M | $7.26M | $10.32M | $8.88M | $6.70M | $7.56M | $7.72M | $4.28M |
| **Cash & Short-Term Investments** | $7.29M | $7.26M | $10.32M | $8.88M | $6.70M | $7.56M | $7.72M | $4.28M |
| **Total Current Assets** | $8.41M | $8.72M | $10.96M | $9.69M | $7.88M | $9.08M | $9.34M | $5.19M |
| Property, Plant & Equipment, Net | $54K | $62K | $70K | $78K | $77K | $99K | $127K | $159K |
| Other Non-Current Assets | $900K | $900K | $900K | $900K | $900K | $900K | -- | $0 |
| **Total Non-Current Assets** | $12.32M | $12.36M | $12.40M | $12.44M | $12.47M | $12.52M | $11.67M | $11.73M |
| **Total Assets** | $20.74M | $21.09M | $23.36M | $22.13M | $20.35M | $21.59M | $21.01M | $16.93M |
| Accounts Payable | $3.69M | $4.34M | $4.57M | $3.51M | $2.12M | $3.72M | $2.71M | $2.03M |
| **Total Current Liabilities** | $6.13M | $9.31M | $7.96M | $6.85M | $5.68M | $7.91M | $6.90M | $5.36M |
| **Total Non-Current Liabilities** | $112K | $187K | $218K | $266K | $41.59M | $17.27M | $326K | $358K |
| **Total Liabilities** | $6.25M | $9.50M | $8.18M | $7.12M | $47.27M | $25.18M | $7.22M | $5.72M |
| **Total Debt (incl. Leases)** | $257K | $292K | $326K | $359K | $390K | $420K | $450K | $478K |
| Common Stock | $1.0K | $7.0K | $5.0K | $0 | $49K | $30K | $14K | $0 |
| Retained Earnings | -$233.0M | -$226.5M | -$218.8M | -$206.0M | -$221.6M | -$196.2M | -$178.3M | -$172.4M |
| Accumulated Other Comp. Income | -$93K | -$64K | -$52K | $10K | -- | -- | -- | -$41K |
| **Total Stockholders' Equity** | $14.49M | $11.59M | $15.18M | $15.01M | -$26.92M | -$3.58M | $13.79M | $11.21M |
| Total Equity | $14.49M | $11.59M | $15.18M | $15.01M | -$26.92M | -$3.58M | $13.79M | $11.21M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$33.56M | -$26.05M | -$29.77M | -$29.02M | -$15.89M | -$17.36M | -$13.21M | -$11.88M | -$9.80M | -$3.93M |
| Depreciation & Amortization | $90K | $126K | $127K | $130K | $164K | $200K | $199K | $68K | $18K | $6.0K |
| Stock-Based Compensation | $1.66M | $1.73M | $1.98M | $2.27M | $2.37M | $1.68M | $1.54M | $1.14M | $707K | $324K |
| Change in Payables | $1.33M | -$468K | $403K | $731K | $235K | -$1.02M | $907K | $436K | $411K | -$41K |
| **Operating Cash Flow** | -$22.73M | -$23.86M | -$23.59M | -$27.64M | -$18.95M | -$17.77M | -$17.20M | -$12.20M | -$7.32M | -$3.77M |
| Capital Expenditure | $0 | -$13K | -$124K | -$67K | -$19K | -$376K | -$52K | -$417K | -$28K | -$21K |
| **Free Cash Flow** | -$22.73M | -$23.88M | -$23.71M | -$27.71M | -$18.97M | -$18.15M | -$17.25M | -$12.62M | -$7.35M | -$3.79M |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -- | -- | $0 | -$100K |
| **Investing Cash Flow** | $0 | -$13K | -$124K | -$67K | -$19K | -$374K | -$51K | -$417K | -$28K | -$121K |
| Common Stock Issued | -- | -- | -- | $0 | $74.68M | $22.56M | $19.29M | -- | -- | -- |
| **Financing Cash Flow** | $27.28M | $4.63M | $4.14M | -$23K | $74.72M | $22.55M | $20.85M | $12.04M | $10.06M | $8.87M |
| **Net Change in Cash** | $4.60M | -$19.27M | -$19.59M | -$27.76M | $55.73M | $4.44M | $3.60M | -$580K | $2.71M | $4.98M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.49M | -$7.63M | -$12.85M | $15.55M | -$25.40M | -$17.81M | -$5.90M | -$6.58M |
| Depreciation & Amortization | $8.0K | $8.0K | $8.0K | $9.0K | $21K | $29K | $31K | $31K |
| Stock-Based Compensation | $393K | $436K | $380K | $459K | $303K | $417K | $485K | $427K |
| Change in Payables | -$650K | -$238K | $1.07M | $1.29M | -$1.48M | $850K | $676K | -$520K |
| **Operating Cash Flow** | -$8.97M | -$6.66M | -$6.11M | -$5.37M | -$7.22M | -$5.58M | -$4.56M | -$5.08M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Free Cash Flow** | -- | -- | -- | -$5.37M | -$7.22M | -$5.58M | -$4.56M | -$5.08M |
| **Investing Cash Flow** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $9.03M | $3.61M | $7.61M | $7.49M | $6.38M | $5.42M | $8.00M | $1.0K |
| **Net Change in Cash** | $25K | -$3.06M | $1.44M | $2.17M | -$854K | -$159K | $3.44M | -$5.13M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -223.6% | -232.4% | -96.3% | -55.6% | -20.1% | -97.7% | -84.8% | -83.2% | -57.3% | -26.2% |
| Return on Assets (ROA) | -151.7% | -153.9% | -77.9% | -50.5% | -18.9% | -59.8% | -52.3% | -60.6% | -50.3% | -23.9% |
| Current Ratio | 1.41x | 0.97x | 3.86x | 9.46x | 20.02x | 5.89x | 3.78x | 2.06x | 3.75x | 3.88x |
| Quick Ratio | 1.30x | 0.80x | 3.46x | 8.95x | 19.58x | 5.20x | 3.01x | 1.85x | 3.48x | 3.72x |
| Debt to Equity | 0.02x | 0.04x | 0.02x | 0.01x | 0.00x | 0.02x | 0.02x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -78.8% | -261.7% | -266.8% | -223.6% | -- | -- | -185.1% | -232.4% |
| Return on Assets (ROA) | -55.1% | -143.8% | -173.4% | -151.7% | -273.7% | -172.8% | -121.5% | -153.9% |
| Current Ratio | 1.37x | 0.94x | 1.38x | 1.41x | 1.39x | 1.15x | 1.35x | 0.97x |
| Quick Ratio | 1.19x | 0.78x | 1.30x | 1.30x | 1.18x | 0.96x | 1.12x | 0.80x |
| Debt to Equity | 0.02x | 0.03x | 0.02x | 0.02x | -- | -- | 0.03x | 0.04x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
